Clinical trial JK06.1.01
A Phase 1/2, Multicenter, Open Label, Dose Escalation and Dose Expansion Study of JK06, a 5T4 Antibody Drug Conjugate, in Patients with Unresectable Locally Advanced or Metastatic Cancer
| Organ | Multiple |
|---|---|
| Trial status | Trial open for recruitment |
| Investigator | |
| Trial type |
Interventional with experimental drug
|
| Phase | Trial phase 1/2 |
| Academic trial | Non |
| Sponsor | Salubris Biotherapeutics, Inc. |
| EudraCT Identifier | 2024-512421-92-00 |
| ClinicalTrials.gov | https://clinicaltrials.gov/ct2/show/NCT04202705 |
| Last update |